Table 2.
Ropivacaine Group (n = 25) |
Placebo Group (n = 25) |
|
---|---|---|
Age, yr | 66 (60–70) | 64 (60–69) |
Sex, F/M | 14/11 | 15/10 |
Height, cm | ||
Male patients | 180 (175–188) | 179 (175–183) |
Female patients | 163 (157–170) | 169 (158–170) |
Weight, kg | ||
Male patients | 108 (82–115) | 88 (75–119) |
Female patients | 82 (73–87) | 73 (68–87) |
Body mass index, kg/m2 | 31 (27–33) | 28 (24–32) |
ASA physical status | II (II–II) | II (II–II) |
Minimum needle current, mA | 0.28 (0.20–0.31) | 0.30 (0.24–0.31) |
Intraoperative fentanyl (µg) | 250 (100–250) | 250 (175–250) |
Intraoperative morphine, mg | 5 (2–10) | 5 (2–8) |
Catheter insertion to randomization, h | 23 (21–23) | 23 (21–23) |
Surgery duration, min | 107 (100–132) | 116 (112–134) |
Tourniquet duration, min | 100 (96–112) | 108 (102–120) |
Values are reported as median (25th–75th percentiles).
ASA = American Society of Anesthesiologists.